Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lung Neoplasms × Fentanyl × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 7 Colonic Neoplasms 3 Cancer Pain 3 Rectal Neoplasms 2 Head and Neck Neoplasms 2 Chronic Pain 2 Agnosia 2 post laminectomy syndrome 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Terminal Cancer 1 Prostatic Neoplasms 1 Postoperative Cognitive Complications 1 Polyps 1 Pleural Effusion, Malignant 1 Patient Satisfaction 1 Pain, Postoperative 1 Neoplasms 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Kidney Neoplasms 1 Ileus 1 Failed Back Surgery Syndrome 1 Emergencies 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Constipation 1 Breakthrough Pain 1 Arrhythmias, Cardiac 1 Acute Pain 1

Interventions

Propofol 5 Sevoflurane 3 Saline Solution 3 Erlotinib Hydrochloride 3 Carboplatin 3 Acetaminophen 3 Nivolumab 2 Midazolam 2 Lidocaine 2 Docetaxel 2 Cryotherapy 2 Bupivacaine 2 Bronchoscopy 2 Anesthesia, Inhalation 2 trametinib 1 sotorasib 1 pegfilgrastim 1 icotinib 1 endostar protein 1 durvalumab 1 dabrafenib 1 capmatinib 1 camrelizumab 1 beta Carotene 1 atezolizumab 1 Zoledronic Acid 1 Vitamin A 1 Tobacco Use Cessation Devices 1 Sunitinib 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02359175 2023-06-27

SEAVATS

Odense University Hospital

Phase 4 Completed

Lung Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡